COSMO VENTURES INC (49) | Business Finance (34)
Browse by Subcategory
Recent Contracts
-
Form of Amendment for all outstanding convertible promissory notes September 30, 2022
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Steve Moses on March 26, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on March 26, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on April 21, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Steve Moses on April 30, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on July 25, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Steve Moses on July 25, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on October 1, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on December 23, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Steve Moses on December 23, 2021
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on January 11, 2022
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on January 31, 2022
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to 0994091 BC Ltd. on March 29, 2022
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Mulsane Ltd. on June 16, 2022
(Filed With SEC on December 14, 2022)
-
Convertible Promissory Note issued to Tulip Enterprises LLC on October 25, 2021
(Filed With SEC on December 14, 2022)
-
Press Release dated April 28, 2022
(Filed With SEC on April 29, 2022)
-
Forward Purchase Agreement between CPHARMACEUTICA DISTRIBUIDORA DE PRODUTOS MEDICOS LTDA and Allied Corp dated as of April 28, 2022
(Filed With SEC on April 29, 2022)
-
Promissory Note dated as of March 30, 2021 from Allied US Products LLC in favor of Marapharm Las Vegas LLC
(Filed With SEC on April 9, 2021)
-
Asset Purchase Agreement dated as of March 30, 2021 between Marapharm Las Vegas LLC and Allied US Products, LLC
(Filed With SEC on April 9, 2021)
-
Convertible Promissory Note issued to Sawasawa, Inc. November 11, 2020
(Filed With SEC on December 16, 2020)
-
Convertible Promissory Note issued to Sawasawa Inc. October 26, 2020
(Filed With SEC on December 16, 2020)
-
Convertible Promissory Note issued to Sawasawa Inc. September 29, 2020
(Filed With SEC on December 16, 2020)
-
Convertible Promissory Note issued to CA Indosuez (Switzerland) S.A. January 23, 2020
(Filed With SEC on December 16, 2020)
-
Series A Warrant issued to CA Indosuez (Switzerland) S.A. January 23, 2020
(Filed With SEC on December 16, 2020)
-
Security Agreement dated as of January 23, 2020 between the Company and CA Indosuez (Switzerland) S.A
(Filed With SEC on December 16, 2020)
-
Convertible Promissory Note issued to Parkward Holding Ltd. January 23, 2020
(Filed With SEC on December 16, 2020)
-
Series A Warrant issued to Parkward Holding Ltd. January 23, 2020
(Filed With SEC on December 16, 2020)
-
Security Agreement dated as of January 23, 2020 between the Company and Parkward Holding Ltd
(Filed With SEC on December 16, 2020)
-
Convertible Promissory Note issued to Allied Special Opportunities Limited February 25, 2020
(Filed With SEC on December 16, 2020)
-
Series A Warrant issued to Allied Special Opportunities Limited February 25, 2020
(Filed With SEC on December 16, 2020)
-
Security Agreement dated as of January 23, 2020 between the Company and Allied Special Opportunities Lit
(Filed With SEC on December 16, 2020)
-
Loan and Security Agreement dated May 14, 2020 between the Company and SLCI1, LLC
(Filed With SEC on December 16, 2020)
-
Promissory Note issued May 14, 2020 from the Company to SLCI1, LLC
(Filed With SEC on December 16, 2020)
-
Share Purchase Agreement between Dorson Commercial Corp. and AD (Advanced Micro) Biosciences, Inc. dated August 29, 2019
(Filed With SEC on October 7, 2020)